Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Murray

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 30, 2019
Patterns of recurrence after prostate bed radiotherapyDouglas H Brand, Joanna I Parker, David P Dearnaley, et al.
The Lancet. Oncology|August 2, 2021
Elective nodal radiotherapy in prostate cancerGert De Meerleer, Charlien Berghen, Alberto Briganti, et al.
Frontiers in Oncology|June 3, 2022
Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer-Prevalence and Current Clinical PracticePriyanka H Patel, Nina Tunariu, Daniel S Levine, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2023
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation TherapyRosalyne Laura Westley, Katie Biscombe, Alex Dunlop, et al.
Clinical and Translational Radiation Oncology|September 2, 2022
Dosimetric comparison of automatically propagated prostate contours with manually drawn contours in MRI-guided radiotherapy: A step towards a contouring free workflow?Kobika Sritharan, Alex Dunlop, Jonathan Mohajer, et al.
Clinical and Translational Radiation Oncology|February 20, 2020
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trialJulia Murray, Sarah Gulliford, Clare Griffin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2019
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancerJulia Murray, Clare Griffin, Sarah Gulliford, et al.
Clinical and Translational Radiation Oncology|October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentationJulia Murray, Clare Cruickshank, Thomas Bird, et al.
Clinical and Translational Radiation Oncology|February 24, 2026
PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRTAngela Pathmanathan, Suneil Jain, John Staffurth, et al.
Technical Innovations & Patient Support in Radiation Oncology|January 19, 2023
Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRIGillian Adair Smith, Alex Dunlop, Sophie E Alexander, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 30, 2019
Patterns of recurrence after prostate bed radiotherapyDouglas H Brand, Joanna I Parker, David P Dearnaley, et al.
The Lancet. Oncology|August 2, 2021
Elective nodal radiotherapy in prostate cancerGert De Meerleer, Charlien Berghen, Alberto Briganti, et al.
Frontiers in Oncology|June 3, 2022
Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer-Prevalence and Current Clinical PracticePriyanka H Patel, Nina Tunariu, Daniel S Levine, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2023
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation TherapyRosalyne Laura Westley, Katie Biscombe, Alex Dunlop, et al.
Clinical and Translational Radiation Oncology|September 2, 2022
Dosimetric comparison of automatically propagated prostate contours with manually drawn contours in MRI-guided radiotherapy: A step towards a contouring free workflow?Kobika Sritharan, Alex Dunlop, Jonathan Mohajer, et al.
Clinical and Translational Radiation Oncology|February 20, 2020
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trialJulia Murray, Sarah Gulliford, Clare Griffin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2019
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancerJulia Murray, Clare Griffin, Sarah Gulliford, et al.
Clinical and Translational Radiation Oncology|October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentationJulia Murray, Clare Cruickshank, Thomas Bird, et al.
Clinical and Translational Radiation Oncology|February 24, 2026
PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRTAngela Pathmanathan, Suneil Jain, John Staffurth, et al.
Technical Innovations & Patient Support in Radiation Oncology|January 19, 2023
Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRIGillian Adair Smith, Alex Dunlop, Sophie E Alexander, et al.
Pageof 3